239 related articles for article (PubMed ID: 11520812)
21. Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation.
Takahashi H; Furukawa T; Hashimoto S; Suzuki N; Kuroha T; Yamazaki F; Inano K; Takahashi M; Aizawa Y; Koike T
Bone Marrow Transplant; 2000 Dec; 26(12):1317-23. PubMed ID: 11223972
[TBL] [Abstract][Full Text] [Related]
22. IL-10 promoter polymorphisms influence susceptibility to aGvHD and are associated with proportions of CD4+FoxP3+ lymphocytes in blood after hematopoietic stem cell transplantation.
Jaskula E; Lange A; Dlubek D; Kyrcz-Krzemień S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Goździk J; Mizia S;
Tissue Antigens; 2013 Dec; 82(6):387-96. PubMed ID: 24498995
[TBL] [Abstract][Full Text] [Related]
23. Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors.
Gaziev D; Polchi P; Galimberti M; Angelucci E; Giardini C; Baronciani D; Erer B; Lucarelli G
Transplantation; 1997 Mar; 63(6):854-60. PubMed ID: 9089226
[TBL] [Abstract][Full Text] [Related]
24. Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor.
Lin MT; Storer B; Martin PJ; Tseng LH; Grogan B; Chen PJ; Zhao LP; Hansen JA
Blood; 2005 Dec; 106(12):3995-4001. PubMed ID: 16109775
[TBL] [Abstract][Full Text] [Related]
25. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in TNFA and TNFR2 affect outcome of unrelated bone marrow transplantation.
Ishikawa Y; Kashiwase K; Akaza T; Morishima Y; Inoko H; Sasazuki T; Kodera Y; Juji T
Bone Marrow Transplant; 2002 Apr; 29(7):569-75. PubMed ID: 11979305
[TBL] [Abstract][Full Text] [Related]
27. Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.
Qayed M; Wang T; Hemmer MT; Spellman S; Arora M; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Aljurf M; Ayas M; Bitan M; Cairo M; Choi SW; Dandoy C; Delgado D; Gale RP; Hale G; Frangoul H; Kamble RT; Kharfan-Dabaja M; Lehman L; Levine J; MacMillan M; Marks DI; Nishihori T; Olsson RF; Hematti P; Ringden O; Saad A; Satwani P; Savani BN; Schultz KR; Seo S; Shenoy S; Waller EK; Yu L; Horowitz MM; Horan J
Biol Blood Marrow Transplant; 2018 Mar; 24(3):521-528. PubMed ID: 29155316
[TBL] [Abstract][Full Text] [Related]
28. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
Front Immunol; 2018; 9():109. PubMed ID: 29456530
[TBL] [Abstract][Full Text] [Related]
29. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
30. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms of interleukin-1alpha constitute independent risk factors for chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Cullup H; Dickinson AM; Cavet J; Jackson GH; Middleton PG
Br J Haematol; 2003 Sep; 122(5):778-87. PubMed ID: 12930389
[TBL] [Abstract][Full Text] [Related]
32. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci.
Li S; Kawata H; Katsuyama Y; Ota M; Morishima Y; Mano S; Kulski JK; Naruse T; Inoko H
Tissue Antigens; 2004 Apr; 63(4):362-8. PubMed ID: 15009808
[TBL] [Abstract][Full Text] [Related]
33. A meta-analysis of the effects of interleukin-6 -174 G>C genetic polymorphism on acute graft-versus-host disease susceptibility.
Choi B; Lee DE; Park HY; Jeong S; Lee SM; Ji E; Park S; Oh JM
Clin Ther; 2012 Feb; 34(2):295-304. PubMed ID: 22304944
[TBL] [Abstract][Full Text] [Related]
34. Association of IL-10 and IL-10Rbeta gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donor.
Sivula J; Turpeinen H; Volin L; Partanen J
BMC Immunol; 2009 May; 10():24. PubMed ID: 19409109
[TBL] [Abstract][Full Text] [Related]
35. T-cell frequency analysis does not predict the incidence of graft-versus-host disease in HLA-matched sibling bone marrow transplantation.
Wang XN; Taylor PR; Skinner R; Jackson GH; Proctor SJ; Hedley D; Dickinson AM
Transplantation; 2000 Aug; 70(3):488-93. PubMed ID: 10949192
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings.
Affaticati P; Locatelli F; Roggero S; Marmont F; Falda M; Dall'Omo AM; Busca A; Ceretto C; Praticò L; Berrino M; Curtoni ES
Bone Marrow Transplant; 2000 Sep; 26(5):517-23. PubMed ID: 11019841
[TBL] [Abstract][Full Text] [Related]
37. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.
Spencer A; Szydlo RM; Brookes PA; Kaminski E; Rule S; van Rhee F; Ward KN; Hale G; Waldmann H; Hows JM; Batchelor JR; Goldman JM
Blood; 1995 Nov; 86(9):3590-7. PubMed ID: 7579468
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation.
Hattori H; Matsuzaki A; Suminoe A; Ihara K; Nagatoshi Y; Sakata N; Kawa K; Okamura J; Hara T
Bone Marrow Transplant; 2002 Nov; 30(10):665-71. PubMed ID: 12420205
[TBL] [Abstract][Full Text] [Related]
40. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation.
Van Lint MT; Uderzo C; Locasciulli A; Majolino I; Scimé R; Locatelli F; Giorgiani G; Arcese W; Iori AP; Falda M; Bosi A; Miniero R; Alessandrino P; Dini G; Rotoli B; Bacigalupo A
Blood; 1998 Oct; 92(7):2288-93. PubMed ID: 9746766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]